Journal of Cervical Cancer
Advancing molecular understanding of HPV-driven pathogenesis through peer-reviewed research on disease mechanisms, biomarker discovery, and cellular pathway analysis
Pathophysiology-Focused Cervical Cancer Research
The Journal of Cervical Cancer (JCC) (ISSN 2997-2108) is a peer-reviewed, open access publication dedicated to exploring the molecular and cellular mechanisms underlying cervical carcinogenesis. As an ISSN-registered, COPE-compliant journal, JCC provides a rigorous platform for disseminating research on how HPV-mediated transformation, biomarker expression, genetic alterations, and cellular pathways drive cervical cancer development and progression.
JCC curates scholarship that decodes the pathophysiological underpinnings of cervical cancer. Our scope emphasizes molecular mechanisms, disease models, pathway analysis, and biomarker validation-domains essential for advancing precision oncology and early detection strategies.
Viral oncogene function (E6/E7), genomic integration sites, viral-host protein interactions, co-factor synergy, and strain-specific virulence mechanisms.
Molecular signatures for early detection, risk stratification, recurrence prediction; protein, RNA, DNA, and metabolite biomarkers; liquid biopsy technologies.
Cell cycle dysregulation, apoptosis evasion, DNA damage response, senescence bypass, stem cell-like phenotypes, and clonal evolution dynamics.
DNA methylation patterns, histone modifications, chromatin remodeling, non-coding RNA regulation, somatic mutations, and chromosomal instability.
Immune cell infiltration, cytokine networks, stromal signaling, extracellular matrix remodeling, angiogenesis pathways, and immune evasion strategies.
Cell line characterization, organoid systems, patient-derived xenografts, CRISPR-based models, and in vitro transformation assays.
HPV genotype distribution, genetic susceptibility loci, population-level biomarker correlations, hereditary risk factors, and gene-environment interactions.
Molecular basis of therapeutic resistance, adaptive cellular responses, biomarkers predictive of drug sensitivity, and pathway-level compensatory signaling.
JCC accepts diverse manuscript formats that advance mechanistic knowledge of cervical cancer pathophysiology. Each format undergoes rigorous peer review by experts in molecular oncology, virology, genomics, and systems biology.
JCC employs a single-blind peer review process emphasizing reproducibility, statistical rigor, and biological relevance. Reviewers assess experimental design, control adequacy, data interpretation, mechanistic logic, and alignment with scope. Authors receive constructive feedback aimed at strengthening scientific claims and methodological transparency.
- Median time to first decision: 12 days
- Rigorous assessment by domain experts in molecular oncology
- Emphasis on data quality, reproducibility, and mechanistic depth
- Clear decision rationales and actionable revision guidance
- Double-blind review available upon request for bias mitigation
JCC streamlines manuscript handling from submission to publication while maintaining rigorous quality standards. Authors benefit from responsive editorial communication, transparent workflows, and rapid online dissemination upon acceptance.
Manuscript Preparation
Review Instructions for Authors for formatting, reporting standards (ARRIVE, MIQE, etc.), and ethical compliance requirements. Ensure mechanistic focus aligns with JCC scope.
Online Submission
Submit via the Manuscript Zone or email to [email protected]. Include cover letter highlighting novelty, mechanistic insights, and scope fit.
Editorial Assessment
Initial screening for scope alignment, ethical compliance, and technical quality. Manuscripts meeting standards proceed to peer review within 3-5 days.
Peer Review
Expert evaluation of experimental design, data interpretation, statistical rigor, and mechanistic conclusions. Authors receive detailed feedback and revision requests.
Revision & Re-Review
Respond to reviewer comments with point-by-point rebuttals and manuscript revisions. Re-review prioritized for rapid decision (typically 7-10 days).
Acceptance & Production
Accepted manuscripts enter production for copyediting, formatting, and proof approval. Authors review proofs within 48 hours for final publication.
Open Access Publication
Immediate online publication with DOI assignment. Articles distributed via indexing platforms and social channels for maximum visibility.
JCC's editorial leadership comprises internationally recognized experts in cervical cancer pathophysiology, HPV biology, molecular oncology, and translational research. Board members guide scope definition, peer review standards, and strategic vision.
Advance Cervical Cancer Pathophysiology Research
Join JCC's global community of molecular oncologists, virologists, and translational researchers uncovering the mechanisms driving HPV-mediated carcinogenesis. Submit your mechanistic discoveries today.
